The test, which screens for chlamydia, gonorrhea, and trichomoniasis, delivers results in 30 minutes and was at least 97% effective in detecting each infection.
In 2023, CMS announced that hospitals would be rewarded for SEP-1 compliance, but studies have cast doubt on its correlation with improved mortality rates.